Gencell S.A.
Records under this name other than patents Gencell S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,364,894 | Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy Formerly held Term ended Term ended Aug 26, 2024 · From the USPTO record | Term ended | Term ended Aug 26, 2024 | From the USPTO record |
| US 7,641,914 | Acid-sensitive compounds, their preparation and uses Term ended Term ended Sep 5, 2023 · From the USPTO record | Term ended | Term ended Sep 5, 2023 | From the USPTO record |
| US RE39,078 | Recombinant adenoviruses for gene therapy in cancers Term ended Term ended Apr 25, 2023 · From the USPTO record | Term ended | Term ended Apr 25, 2023 | From the USPTO record |
| US 6,812,218 | Lipid derivatives of polythiourea Term ended Term ended Nov 9, 2022 · From the USPTO record | Term ended | Term ended Nov 9, 2022 | From the USPTO record |
| US 7,052,838 | Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction Formerly held Term ended Term ended Jun 8, 2022 · From the USPTO record | Term ended | Term ended Jun 8, 2022 | From the USPTO record |
| US 6,825,341 | Process for Preparing Functionalized Polyalkyleneimines, Compositions Containing Them and Uses Thereof Term ended Term ended May 1, 2021 · High confidence | Term ended | Term ended May 1, 2021 | High confidence |
| US 6,410,298 | Adenovirus vectors and method for reducing homologous recombination phenomena Formerly held Term ended Term ended Sep 11, 2020 · From the USPTO record | Term ended | Term ended Sep 11, 2020 | From the USPTO record |
| US 6,319,672 | Purification of a triple helix formation with an immobilized oligonucleotide Formerly held Term ended Term ended May 26, 2020 · From the USPTO record | Term ended | Term ended May 26, 2020 | From the USPTO record |
| US 6,387,670 | Method for producing recombinant virus Formerly held Term ended Term ended May 18, 2019 · From the USPTO record | Term ended | Term ended May 18, 2019 | From the USPTO record |
| US 6,977,174 | Circular DNA molecule with conditional origin of replication, method for preparing the same and use thereof in gene therapy Formerly held Term ended Term ended Oct 18, 2017 · From the USPTO record | Term ended | Term ended Oct 18, 2017 | From the USPTO record |